Review Article
The Development and Application of a Base Editor in Biomedicine
Table 2
Summary of application of base editor in gene therapy.
| First author | Publication years | Species (tissues) | Category of base editor | Delivery | Disease | Gene | Mutation efficiency | Off-target |
| Alexis C. Komor [15] | 2016 | Mouse astrocytes | BE3 | Plasmids | Alzheimer’s disease | APOE4 | 58-75% | 4.6–6.1% indels at the targeted locus | Alexis C. Komor [15] | 2016 | Human cell | BE3 | Plasmids | Breast cancer | P53 | 3.3-7.6% | ≤0.7% indel formation | Puping Liang [50] | 2017 | Human embryos | YEE-BE3 | Injecting mRNA and gRNA | β-Thalassemia | HBB | 22.9% | No off-target in top 10 predicted sites | Alexandra C. Chadwick [82] | 2017 | Adult mice | BE3 | Adenoviral vectors | High blood cholesterol | PCSK9 | Average 24% | ≤1% indel formation | Seuk-Min Ryu [70] | 2018 | Adult mice | ABE | Adeno-associated virus | Duchenne muscular dystrophy | DMD | | No off-target mutations at homologous sites with up to three mismatches | Luke W Koblan [20] | 2018 | Human fibroblasts | BE4, BE4max–P2A–GFP, AncBE4max–P2A–GFP | Plasmids | Glycosylation type 1f | MPDU1 | 32-77% | N.R. | Lukas Villiger [76] | 2018 | Adult mice | nSaKKH-BE3 | Adeno-associated virus | Autosomal recessive liver disease phenylketonuria | PAH | Average 25.1% | No C∙ G to T∙ A conversions or indel formations in ten potential off-target loci | dLbRR-BE | Alexandra C. Chadwick [83] | 2018 | Adult mice | BE3 | Adenoviral vectors | Hyperlipidemic | ANGPTL3 | 35% | No off-target in top 10 predicted sites | Yanting Zeng [84] | 2018 | Human embryos | BE3 | Injecting mRNA and gRNA | Marfan syndrome | FBNA | 89% | No off-target and indels were detected in 32 potential off-target sites | Maria Paz Zafra [85] | | Mouse intestinal organoids | FNLS-BE3 | Plasmids | Colorectal cancers19 | Apc | >97% | Less than 1% indels | Xinjian Li [54] | 2020 | Human U87 and U251 cells | CjABE | Adeno-associated virus | Glioblastoma | TERT | 70-80% | N.R. | Xiang Lin [56] | 2020 | Human SMA motor neurons | SaCas9n-KKH-ABE | Injecting mRNA and gRNA | Spinal muscular atrophy | SMN2 | 5-40% | No detectable off-target effects in DNA level | Colin K.W.Lim [78] | 2020 | Adult mice | BE3 | Adeno-associated virus | Amyotrophic lateral sclerosis | SOD1 | N.R. | N.R. | Chun Qing Song [86] | 2020 | Adult mice | ABE6.3 | Plasmids | Tyrosinemia | FAH | | One off-target site | Jonathan M. Levy [87] | 2020 | Adult mice | BE3 | Adeno-associated virus | Niemann-pick disease | Npc1 | 10-80% | One off-target site |
|
|